Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Results data for the study were posted on the page, including outcome measures and updated study record dates. The update provides accessible information on the trial outcomes directly within the study record.
    Difference
    0.4%
    Check dated 2025-11-03T12:38:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T17:25:53.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated terminology to Squamous cell carcinoma of the head and neck and bumped the revision to v3.1.0, reflecting a terminology update and new version. Earlier term Head and neck squamous cell carcinoma and revision v3.0.2 were removed.
    Difference
    0.6%
    Check dated 2025-09-28T10:14:34.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:20:19.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:10:10.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, adding specific references to various cancers and related resources, while removing some previous location terms and outdated references.
    Difference
    4%
    Check dated 2025-08-30T15:42:19.000Z thumbnail image

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.